BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
The IN-ARMOR project continues to gain visibility beyond the scientific community. On 12 June 2026, SPRI (Basque Agency for Business Development) published an article on its blog dedicated to I+D+i, highlighting IN-ARMOR as a European initiative exploring new ways to combat antimicrobial…
IN-ARMOR Consortium Strategize for Upcoming Project Review and Clinical Transitions On May 28, 2026, our team joined work package leaders and key representatives from the partners for the 13th Management Board Meeting (MBM13). This virtual gathering was vital for evaluating recent project…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value